clinical / clinicalBone Marrow Transplant

Mohamad Mohty

穆罕默德·莫蒂

MD, PhD

🏢Hôpital Saint-Antoine, Sorbonne University(索邦大学圣安托万医院)🌐France

Head, Hematology and Cell Therapy Department血液学与细胞治疗科主任

h-index

Key Papers

Awards

Key Contributions

👥Biography 个人简介

Mohamad Mohty heads the hematology and cell therapy department at Hôpital Saint-Antoine in Paris, leading European research on allogeneic HSCT for multiple myeloma, haploidentical transplantation, and novel GvHD prophylaxis in France and through EBMT.

🧪Research Fields 研究领域

Allogeneic HSCT异基因造血干细胞移植

Multiple Myeloma Transplant多发性骨髓瘤移植

Graft-versus-Host Disease移植物抗宿主病

Haploidentical Transplant半相合移植

Reduced Intensity Conditioning减低强度预处理

🎓Key Contributions 主要贡献

Allogeneic HSCT in Multiple Myeloma

Led pivotal EBMT analyses defining the role and optimal timing of allogeneic transplantation in myeloma, identifying patient subsets most likely to achieve durable remissions with acceptable toxicity.

Haploidentical and RIC Transplant

Advanced reduced intensity conditioning regimens and haploidentical transplantation in Europe, publishing key comparative studies and establishing French national protocols adopted across EBMT member centers.

Representative Works 代表性著作

[1]

Allogeneic stem cell transplantation for multiple myeloma in the era of novel agents: a report from the EBMT

Blood (2020)

Comprehensive EBMT registry analysis redefining allo-SCT indications in myeloma in the context of novel therapies.

[2]

Haploidentical versus matched unrelated donor transplantation for relapsed/refractory Hodgkin lymphoma

Haematologica (2022)

European multi-center comparison demonstrating non-inferior outcomes with haplo approach enabling broader access.

🏆Awards & Recognition 奖项与荣誉

🏆EBMT President (2020–2022)

🏆French Society of Hematology Award

🏆Sorbonne University Research Excellence Award

📄Data Sources 数据来源

Institution

Last updated: 2026-01-15 | All information from publicly available academic sources

Related Experts 相关专家

Hope S. Rugo

University of California, San Francisco (UCSF)

Antibody-Drug Conjugates in Metastatic Breast CancerASCENT Trial and Sacituzumab Govitecan

Maryam B. Lustberg

Yale School of Medicine / Yale Cancer Center

Cardiotoxicity of CDK4/6 Inhibitors and Endocrine TherapyCancer Treatment-Related Cardiovascular Disease

Sara M. Tolaney

Dana-Farber Cancer Institute / Harvard Medical School

T-DM1 and KATHERINE Trial in Residual Disease After Neoadjuvant TherapyTrastuzumab Deruxtecan (T-DXd) and DESTINY-Breast Trials

Carlos H. Barrios

PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil

CDK4/6 Inhibitors in Low- and Middle-Income Countries (LMIC)Global Breast Cancer Clinical Trials and Access

关注穆罕默德·莫蒂的研究动态

Follow Mohamad Mohty's research updates

留下邮箱，当我们发布与 Mohamad Mohty（Hôpital Saint-Antoine, Sorbonne University）相关的新研究或访谈时，我们会通知你。

Explore More Experts

Discover the researchers shaping the future of cancer treatment

Browse All Experts Read Research Insights

International Translational Oncology Exchange